Their final consensus list was conformed by 99 mutational BC driver genes, of them, 34 were identified by the OncoOmics strategy (TP53, PIK3CA, KMT2C, GATA3, CDH1, MAP3K1, ESR1, PTEN, AKT1, NCOR1, ARID1A, MAP2K4, FOXA1, NF1, ERBB2, RB1, SF3B1, ERBB3, CTCF, PIK3R1, ATM, FGFR2, BRCA1, CASP8, CREBBP, BRCA2, CDKN2A, KRAS, CDKN1B, NOTCH2, MAX, MDM4, EGFR and JAK2). This evidence concerns the gene JAK2 and breast cancer.